Blood Transfusion Strategies in Upper GI Bleeding
Data Collection
Collected from today forward - ProspectiveCohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: May 22, 2025
Actual date on which the first participant was enrolled.This study focuses on understanding the best approach to blood transfusions in patients suffering from upper gastrointestinal (GI) bleeding at Sohag University Hospital. It compares two different blood transfusion strategies: a liberal approach where the target hemoglobin level is maintained at 9-11 grams per deciliter, and a restrictive approach with a target of 7-9 grams per deciliter. The research aims to identify which strategy is safer and more effective, particularly taking into account other health conditions the patients might have, such as liver cirrhosis or chronic kidney disease, and the specific causes of their bleeding. This study is important as it could help refine treatment protocols and reduce complications in patients with upper GI bleeding. The study is observational, meaning it does not involve assigning specific treatments but rather observes the outcomes of the two transfusion strategies. Participants will undergo blood transfusions to reach the target hemoglobin levels as specified by either the liberal or restrictive strategy. Researchers will then monitor these patients to evaluate the rate of complications and any unwanted effects that occur after the transfusions. The main goal is to determine which method leads to better health outcomes and fewer complications, thus informing future treatment guidelines for similar patients.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.200 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 100 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Faculty of medicine sohag university
Sohag, EgyptOpen Faculty of medicine sohag university in Google Maps